Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mangalam Drugs and Organics Ltd

NSE: MANGALAM · BSE: 532637 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹33.09
Market cap
₹52.38 Cr
Revenue (annual)
₹232.1 Cr
Net profit (annual)
₹-44.40 Cr
P/E (TTM)
-1.4×Sector 47.3×
Promoter holding
35.65%+0.00% QoQ
FII holding
0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:11 IST BSE
Annual General Meeting

Mangalam Drugs and Organics Annual General Meeting

Mangalam Drugs and Organics Ltd held its 53rd Annual General Meeting on September 23, 2026. The meeting transacted standard business items including financial statement adoption and auditor appointments.

17:52 IST BSE
Annual General Meeting

Mangalam Drugs and Organics Annual General Meeting

Mangalam Drugs and Organics Limited scheduled its 53rd Annual General Meeting for September 23, 2026. The meeting will be held via video conferencing.

17:32 IST BSE
Annual General Meeting

Mangalam Drugs and Organics Annual General Meeting

Mangalam Drugs and Organics seeks shareholder approval via postal ballot for Shri Praveen Saxena's re-appointment. E-voting commences May 19, 2026, for a second five-year term.

Execution
5 years